| Authors: |
Munk C; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. christian.munk@sund.ku.dk., Mutt E; Paul Scherrer Institute, Villigen, Switzerland., Isberg V; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Novozymes A/S, Copenhagen, Denmark., Nikolajsen LF; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Bibbe JM; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Flock T; Paul Scherrer Institute, Villigen, Switzerland., Hanson MA; GPCR Consortium, San Marcos, CA, USA., Stevens RC; Departments of Biological Sciences and Chemistry, Bridge Institute, USC Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA, USA.; iHuman Institute, ShanghaiTech University, Shanghai, China., Deupi X; Paul Scherrer Institute, Villigen, Switzerland., Gloriam DE; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark. david.gloriam@sund.ku.dk. |
